Terms: = Lung cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3
55 results:
1. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
2. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
[TBL] [Abstract] [Full Text] [Related]
3. Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors.
Swart EM; Noordhof AL; Damhuis RAM; Kunst PWA; De Ruysscher DKM; Hendriks LEL; van Geffen WH; Aarts MJ
Lung Cancer; 2023 Aug; 182():107290. PubMed ID: 37419045
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of primary pulmonary rhabdomyosarcoma in middle-aged and elderly patients: a case report and literature review.
Xiaoxia J; Guihua Z; Jiatai W; Xinghua Z; Xudong C; Yingze W
J Int Med Res; 2023 Mar; 51(3):3000605231159782. PubMed ID: 36883437
[TBL] [Abstract] [Full Text] [Related]
5. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
[TBL] [Abstract] [Full Text] [Related]
6. Differential Diagnosis in Hypophysitis: First Report on a Spindle Cell Rhabdomyosarcoma of the Pituitary Gland.
Ahmeti H; Jüttner E; Röcken C; Jansen O; Laudes M; Synowitz M
J Neurol Surg A Cent Eur Neurosurg; 2023 May; 84(3):295-299. PubMed ID: 34781400
[TBL] [Abstract] [Full Text] [Related]
7. Mutational landscape of primary pulmonary salivary gland-type tumors through targeted next-generation sequencing.
Wang F; Xi SY; Hao WW; Yang XH; Deng L; Xu YX; Wu XY; Zeng L; Guo KH; Wang HY
Lung Cancer; 2021 Oct; 160():1-7. PubMed ID: 34364112
[TBL] [Abstract] [Full Text] [Related]
8. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
Rodgers S; Datta L; Perry KD; Stone CH
Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
[TBL] [Abstract] [Full Text] [Related]
9. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract] [Full Text] [Related]
10. Deficient muscle regeneration potential in sarcopenic COPD patients: Role of satellite cells.
Sancho-Muñoz A; Guitart M; Rodríguez DA; Gea J; Martínez-Llorens J; Barreiro E
J Cell Physiol; 2021 Apr; 236(4):3083-3098. PubMed ID: 32989805
[TBL] [Abstract] [Full Text] [Related]
11. [Analysis of clinicopathological features of clear cell tumor of the lung].
Liu Y; Zhang XH; Wang BT; Shen LL; Yuan J; Chen W; Gao J; Shi HY
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(22):1736-1740. PubMed ID: 32536096
[No Abstract] [Full Text] [Related]
12. Pleuropulmonary blastoma type I might arise in congenital pulmonary airway malformation type 4 by acquiring a Dicer 1 mutation.
Brcic L; Fakler F; Eidenhammer S; Thueringer A; Kashofer K; Kulka J; Popper H
Virchows Arch; 2020 Sep; 477(3):375-382. PubMed ID: 32193603
[TBL] [Abstract] [Full Text] [Related]
13. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract] [Full Text] [Related]
14. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
[TBL] [Abstract] [Full Text] [Related]
15. The myod family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity.
Chen CJ; Yang CJ; Yang SF; Huang MS; Liu YP
Oncogene; 2020 Mar; 39(11):2377-2390. PubMed ID: 31911618
[TBL] [Abstract] [Full Text] [Related]
16. Small bowel metastasis from pulmonary rhabdomyosarcoma causing intussusception: a case report.
Sun KK; Shen XJ
BMC Gastroenterol; 2019 May; 19(1):71. PubMed ID: 31077145
[TBL] [Abstract] [Full Text] [Related]
17. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract] [Full Text] [Related]
18. Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation.
Codenotti S; Faggi F; Ronca R; Chiodelli P; Grillo E; Guescini M; Megiorni F; Marampon F; Fanzani A
Cancer Lett; 2019 May; 449():135-144. PubMed ID: 30771426
[TBL] [Abstract] [Full Text] [Related]
19. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S; Richter J; Guilhot J; Gruber FX; Hjorth-Hansen H; Almeida A; Janssen JJWM; Mayer J; Koskenvesa P; Panayiotidis P; Olsson-Strömberg U; Martinez-Lopez J; Rousselot P; Vestergaard H; Ehrencrona H; Kairisto V; Machová Poláková K; Müller MC; Mustjoki S; Berger MG; Fabarius A; Hofmann WK; Hochhaus A; Pfirrmann M; Mahon FX;
Lancet Oncol; 2018 Jun; 19(6):747-757. PubMed ID: 29735299
[TBL] [Abstract] [Full Text] [Related]
20. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract] [Full Text] [Related]
[Next]
